Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meike Harms

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Pharmaceutical Research|June 13, 2012
Development of a new method to assess nanocrystal dissolution based on light scatteringKatharina Anhalt, Simon Geissler, Meike Harms, et al.
Molecular Pharmaceutics|March 29, 2019
Miniaturized Measurement of Drug-Polymer Interactions via Viscosity Increase for Polymer Selection in Amorphous Solid DispersionsCarolin Auch, Meike Harms, Yury Golitsyn, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 24, 2019
Acid-induced degradation of widely used NIR dye DiR causes hypsochromic shift in fluorescence propertiesMarkus Riehl, Meike Harms, Benedikt Göttel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 7, 2018
Dual dye in-vivo imaging of differentially charged PLGA carriers reveals antigen-depot effect, leading to improved immune responses in preclinical modelsMarkus Riehl, Meike Harms, Henrike Lucas, et al.
International Journal of Pharmaceutics|September 4, 2017
Combining R-DOTAP and a particulate antigen delivery platform to trigger dendritic cell activation: Formulation development and in-vitro interaction studiesMarkus Riehl, Meike Harms, Andrea Hanefeld, et al.
Molecular Pharmaceutics|August 24, 2025
PROTAC Enabling Formulation <i>In Vivo</i>: Implications of the Polymeric Carrier Eudragit E PONicole Hofmann, Florian Johann, Katharina Krollik, et al.
Alternatives to Laboratory Animals : ATLA|June 5, 2008
The physicochemical parameters of marker compounds and vehicles for use in in vitro percutaneous absorption studiesMonika Kaca, Udo Bock, Mohamed Tawfik Jalal, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2011
Structural properties of so-called NSAID-phospholipid-complexesJan Hüsch, Bercem Dutagaci, Clemens Glaubitz, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Pharmaceutical Research|June 13, 2012
Development of a new method to assess nanocrystal dissolution based on light scatteringKatharina Anhalt, Simon Geissler, Meike Harms, et al.
Molecular Pharmaceutics|March 29, 2019
Miniaturized Measurement of Drug-Polymer Interactions via Viscosity Increase for Polymer Selection in Amorphous Solid DispersionsCarolin Auch, Meike Harms, Yury Golitsyn, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 24, 2019
Acid-induced degradation of widely used NIR dye DiR causes hypsochromic shift in fluorescence propertiesMarkus Riehl, Meike Harms, Benedikt Göttel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 7, 2018
Dual dye in-vivo imaging of differentially charged PLGA carriers reveals antigen-depot effect, leading to improved immune responses in preclinical modelsMarkus Riehl, Meike Harms, Henrike Lucas, et al.
International Journal of Pharmaceutics|September 4, 2017
Combining R-DOTAP and a particulate antigen delivery platform to trigger dendritic cell activation: Formulation development and in-vitro interaction studiesMarkus Riehl, Meike Harms, Andrea Hanefeld, et al.
Molecular Pharmaceutics|August 24, 2025
PROTAC Enabling Formulation <i>In Vivo</i>: Implications of the Polymeric Carrier Eudragit E PONicole Hofmann, Florian Johann, Katharina Krollik, et al.
Alternatives to Laboratory Animals : ATLA|June 5, 2008
The physicochemical parameters of marker compounds and vehicles for use in in vitro percutaneous absorption studiesMonika Kaca, Udo Bock, Mohamed Tawfik Jalal, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2011
Structural properties of so-called NSAID-phospholipid-complexesJan Hüsch, Bercem Dutagaci, Clemens Glaubitz, et al.
Pageof 2